Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07659652 · ClinicalTrials.gov registry record
Quality of Life for Patients With Breast Cancer Brain Metastases and Leptomeningeal Disease
A clinical trial, sponsored by University of California, San Francisco.
- Not yet
- Registry status
- 200
- Enrollment target
NCT07659652 is a clinical trial that has not yet begun recruiting, run by University of California, San Francisco. The registered enrollment target is 200 participants.
The verdict
NCT07659652 has not yet begun recruiting, sponsored by University of California, San Francisco.
- NOT YET RECRUITING
- Registry status
- 200 participants
- Enrollment target
Study Summary
Central nervous system (CNS) metastases including breast cancer brain metastases (BCBMs) and leptomeningeal disease (LMD) are common affecting up to 30% of patients with metastatic breast cancer (MBC). The goal of this research is to understand symptom burden and quality of life trajectories in this population and how treatments guide care management decisions.
Interventions
- OTHER Medical Chart Review
- OTHER Health-Related Quality of Life (QOL) questionnaires
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2026-06-15 |
| Est. Completion | 2035-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07659652
The ClinicalTrials.gov registry entry for NCT07659652 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Medical Chart Review is the first listed.
NCT07659652 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07659652 about?
NCT07659652 is a clinical study titled "Quality of Life for Patients With Breast Cancer Brain Metastases and Leptomeningeal Disease". Central nervous system (CNS) metastases including breast cancer brain metastases (BCBMs) and leptomeningeal disease (LMD) are common affecting up to 30% of patients with metastatic breast cancer (MBC). The goal of this research is to understand symptom burden and quality of life trajectories in this...
What is the current status of trial NCT07659652?
This trial is currently not yet recruiting. The enrollment target is 200 participants. The study started on 2026-06-15. Estimated completion is 2035-12-31.
What interventions are being tested in trial NCT07659652?
The interventions under investigation include: Medical Chart Review (OTHER), Health-Related Quality of Life (QOL) questionnaires (OTHER).
Who is sponsoring clinical trial NCT07659652?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.